POINT Biopharma Confirms No Supply Shortages of 177Lu-PNT2002 for the SPLASH Trial
Clinical doses continue to be manufactured and shipped from the Company’s Indianapolis, Indiana facility INDIANAPOLIS,…
News
NuriFootBall (NRFB) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – May 5, 2022) – LBank Exchange, a global digital asset…
Datametrex Reports Insider Share Purchase and Share Buyback
Toronto, Ontario–(Newsfile Corp. – May 5, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB:…
AlmaLinux, Popular CentOS Alternative, Now Available on Oracle Cloud
Available on Oracle Cloud Marketplace with x86_64 and Aarch64 support PALO ALTO, Calif.–(BUSINESS WIRE)–AlmaLinux OS…
KBRA Assigns Preliminary Ratings to Freddie Mac’s STACR 2022-DNA4
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to 34 classes from Freddie Mac Structured Agency Credit…
Median Technologies Is Moving Forward With the FDA Interactions for Its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
Median has received the FDA’s feedback following the 513(g) regulatory submission for its iBiopsy® LCS…
Next Level Loan Officers Welcomes Jason Frazier to its Coaching Team
Frazier was drawn to Next Level Loan Officers’ holistic approach to coaching and commitment to…
Construction Management Consultancy Linesight Names Three Additions to Executive Committee
Industry leader augments management team and surpasses 1000 global employee threshold NEW YORK–(BUSINESS WIRE)–Global construction…
CORRECTING and REPLACING DocGo Expands Mobile Health Services to Empire BlueCross BlueShield Members
Leading Mobile Health Services and Transportation Provider Expands New York Presence, Brings In-home Medical Care…
GCC (Gulf Cooperation Council) Color Cosmetics Market Report 2022: Latest Trends, Competition Analysis, and Business Opportunities, 2022-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “GCC Color Cosmetics Market Report: By Type, Product, Packaging, Consumer Group, Distribution Channel…
CoreStack & Persistent Announce Global Partnership to Accelerate Digital Transformation in Multi-Cloud Environments
CoreStack’s Next-Gen Cloud Governance Powers the Persistent Intelligent Operations Solution BELLEVUE, Wash. & SANTA CLARA,…
RealPage® Earns 2022 ENERGY STAR® Partner of the Year Award
EPA, Department of Energy recognize real estate innovator’s outstanding sustainability achievements for the second consecutive…
OneReach.ai Receives Highest Scores in Customer Service and Human Resources Use Cases in the Inaugural 2022 Gartner® Critical Capabilities for Enterprise Conversational AI Platforms Report
DENVER–(BUSINESS WIRE)–#AI—OneReach.ai, creators of a market-leading platform that’s democratizing conversational AI and machine learning with…
ServiceNow Ecosystem Helps U.S. Firms Rein in Complexity
The fast-growing workflow platform is easing application and function sprawl at U.S. enterprises in many…
JPMorgan Chase Launches Advancing Black Wealth Tour to Promote Generational Wealth-Building in Black Communities
Tour to offer insights on financial health, the path to homeownership and entrepreneurship in Los…
TEOCO joins Google Cloud Partner Advantage Program
FAIRFAX, VA., USA – 5 May 2022 – TEOCO, the leading provider of analytics, assurance…
Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial
The IND application for this pilot trial to evaluate oral growth hormone secretagogue, LUM-201, in…
Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program
– $209.7 Million Cash and Cash Equivalents at March 31, 2022 – – Over 120…
Turning Point Therapeutics Announces Pipeline Expansion, Licensing of TPX-4589 (LM-302), A Clinical Stage Anti-Claudin18.2 Antibody Drug Conjugate for Gastrointestinal Cancers, From Lanova Medicines
Strategic Expansion of Turning Point Precision Oncology Portfolio TPX-4589 (LM-302) Currently in Two Ongoing Phase…
Myriad Genetics Reports First Quarter Revenue and Reiterates Guidance for 2022
Highlights: Revenue of $164.9 million for the quarter ended March 31, 2022 Excluding revenue from…